Nevro Corp. (NVRO)
NYSE: NVRO
· Real-Time Price · USD
5.84
0.00 (0.00%)
At close: Apr 02, 2025, 3:59 PM
Nevro Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 105.55M | 96.91M | 104.16M | 101.9M | 116.18M | 103.86M | 108.81M | 96.33M | 113.84M | 100.47M | 104.21M | 87.84M | 102.76M | 93.2M | 102.33M | 88.61M |
Cost of Revenue | 39.63M | 32.3M | 36.69M | 34.34M | 37.72M | 34.35M | 34.37M | 31.7M | 38.6M | 31.16M | 31.48M | 28.75M | 33.63M | 28.57M | 32.34M | 26.32M |
Gross Profit | 65.92M | 64.61M | 67.47M | 67.56M | 78.45M | 69.52M | 74.44M | 64.62M | 75.24M | 69.3M | 72.73M | 59.09M | 69.13M | 64.63M | 69.99M | 62.29M |
Operating Income | -51.41M | -13.87M | -25.12M | -32.36M | -11.79M | -25.56M | -25.64M | -36.32M | -19.36M | -22.92M | -23.79M | -32.77M | -26.21M | -46.44M | -15.76M | -22.51M |
Interest Income | 2.98M | 3.23M | 3.32M | 3.78M | 3.95M | 3.59M | 3.35M | 3.28M | 2.47M | 1.13M | 282K | 143K | 112K | 99K | 163K | 297K |
Pretax Income | -52.94M | -15.06M | -19.31M | -25.03M | -15.56M | -23.35M | -24.25M | -34.7M | -18.84M | 81.99M | -24.75M | -34.14M | -30.21M | -50M | -21.39M | -29.22M |
Net Income | -53.11M | -15.34M | -19.57M | -25.41M | -8.98M | -23.48M | -24.72M | -35.03M | -19.19M | 81.51M | -24.99M | -34.33M | -30.13M | -50.08M | -21.59M | -29.56M |
Selling & General & Admin | 76.2M | 68.47M | 76.77M | 85.09M | 77.82M | 81.15M | 86.76M | 86.19M | 80.65M | 78.19M | 83.97M | 79.33M | 82.64M | 79.52M | 73.88M | 73.27M |
Research & Development | 11.99M | 10.58M | 14.12M | 14.83M | 12.42M | 13.92M | 13.32M | 14.76M | 13.95M | 14.03M | 12.55M | 12.54M | 12.71M | 11.55M | 11.87M | 11.53M |
Other Expenses | 29.14M | -570K | 1.7M | -21K | -436K | 234K | -338K | -46K | -333K | 391K | 368K | 85K | -299K | 30K | -88K | -457K |
Operating Expenses | 117.33M | 78.48M | 92.59M | 99.92M | 90.24M | 95.08M | 100.08M | 100.95M | 94.6M | 92.22M | 96.53M | 91.86M | 95.35M | 91.07M | 85.75M | 84.81M |
Interest Expense | 6.63M | 7.01M | 6.74M | 6.51M | 3.17M | 1.62M | 1.62M | 1.61M | 1.61M | 1.61M | 1.61M | 1.6M | 3.81M | 3.69M | 5.7M | 6.55M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 156.96M | 110.78M | 129.28M | 134.26M | 127.96M | 129.42M | 134.45M | 132.65M | 133.2M | 123.38M | 128M | 120.61M | 128.97M | 119.65M | 118.09M | 111.12M |
Income Tax Expense | 169K | 280K | 262K | 382K | -6.58M | 130K | 477K | 325K | 356K | 485K | 241K | 181K | -78K | 72K | 198K | 342K |
Shares Outstanding (Basic) | 37.62M | 37.32M | 36.94M | 36.47M | 36.28M | 36.14M | 35.92M | 35.58M | 35.47M | 36.75M | 35.2M | 35.07M | 34.97M | 34.77M | 34.81M | 34.63M |
Shares Outstanding (Diluted) | 37.62M | 37.32M | 36.94M | 36.47M | 36.28M | 36.14M | 35.92M | 35.58M | 35.47M | 37.34M | 35.32M | 35.07M | 34.97M | 34.88M | 34.81M | 34.63M |
EPS (Basic) | -1.41 | -0.41 | -0.53 | -0.7 | -0.25 | -0.65 | -0.69 | -0.98 | -0.54 | 2.22 | -0.71 | -0.98 | -0.86 | -1.44 | -0.62 | -0.85 |
EPS (Diluted) | -1.41 | -0.41 | -0.53 | -0.7 | -0.25 | -0.65 | -0.69 | -0.98 | -0.54 | 2.18 | -0.71 | -0.98 | -0.86 | -1.44 | -0.62 | -0.85 |
EBITDA | -43.01M | -4.79M | -9M | -14.55M | -9.37M | -18.88M | -19.85M | -30.46M | -14.63M | 86.25M | -20.55M | -30.04M | -24M | -44.13M | -13.59M | -20.68M |
EBIT | -46.32M | -8.06M | -12.57M | -18.52M | -12.39M | -21.73M | -22.63M | -33.09M | -17.22M | 83.6M | -23.14M | -32.54M | -26.4M | -46.31M | -15.69M | -22.67M |
Depreciation & Amortization | 3.3M | 3.27M | 3.57M | 3.97M | 3.02M | 2.85M | 2.78M | 2.63M | 2.59M | 2.65M | 2.59M | 2.5M | 2.4M | 2.19M | 2.1M | 1.99M |